Objective:In this study,we observed and compared the effects of Buzhong Yiqi method combined with transrectal repair of rectocele with simple transrectal repair of rectocele for low moderate severe rectal proptosis,and concluded a better treatment plan for low moderate severe rectal proptosis,to provid guidance for clinical treatment.Methods:In this study,60 cases who met the diagnostic criteria of low moderate to severe rectal proptosis at the anorectal Department,Affiliated Hospital of Shandong University of traditional Chinese medicine(TCM),between September 2020 and September 2022,were enrolled,and the patients were randomly divided into a treatment group(underwent transrectal repair of rectocele combined with Buzhong Yiqi Decoction plus minus oral intake)and a control group(underwent transrectal repair of rectocele)of 30 cases each.Before and after treatment,defecation scores,TCM symptom quantification scores,and the depth of rectal protrusion under defecation contrast were compared between the two groups.The data obtained were analyzed by SPSS 26.0.Results:The defecation scores,TCM symptom quantification scores,and the depth of proptosis on defecation contrast at 1 week and 6 months after treatment in both groups were decreased compared with that before treatment,P<0.05,indicating that both treatments had therapeutic effects on low-grade moderate to severe rectal proptosis.The overall effective rate was 100%in the treatment group and 86.21%in the control group,and the difference between the treatment group and the control group was statistically significant(P<0.05),which indicated that the Buzhong Yiqi method combined with transrectal repair of rectocele was more effective than transrectal repair of rectocele alone in patients with RC.(1)After 1 week of treatment,there was no statistically significant difference in the patients’ stool scores between the two groups(P>0.05).After 6 months of treatment,the patients in the treatment group had significantly(P<0.01)higher defecation scores than the control group,and the application of the Buzhongyiqi method combined with transrectal repair of rectocele was associated with better outcomes than the application of the Buzhongyiqi method alone.Compared the pre-treatment with the post-treatment group,the fecal properties scores of the treated groups were P>0.05,and all the others were P<0.05,indicating that the application of the Buzhongyiqi method in combination with transrectal repair of rectocele is not effective in improving the patients’ defecation impersistence,anal falling sensation,difficulty in defecating,increasing the number of stools,shortening the defecation time,and improving the fecal properties,respectively.(2)After 1 week of treatment,both groups were equivalent in improving TCM symptoms(P>0.05).After 6 months of treatment,there was a significant difference(P<0.01)between the treatment groups compared with the control group,indicating that with the extension of treatment time,the treatment group was more effective in improving TCM symptoms than the control group.(3)After 6 months of treatment,there was a significant difference(P<0.01)in the depth of anterior protrusion on defecography between the treatment groups compared with the control group,indicating that both treatment regimens were effective in shrinking the depth of anterior protrusion in RC patients,but the treatment groups were more effective.Conclusions:In this study,we proved that the combination of Buzhong Yiqi method with transrectal repair of rectocele,as well as the simple operation of transrectal repair of rectocele,can significantly improve the symptoms of patients with low moderate to severe rectoprostasis,which when treated surgically,can rapidly improve the defecation difficulties caused by anatomical changes,but the combination of Buzhong Yiqi method after surgery can improve the general condition of patients,while reducing postoperative recurrence and enhancing the effect of surgical treatment.This program adopts the way of integrated traditional Chinese and Western medicine,and has a high clinical effectiveness rate and a good safety profile,which is worthy of promotion and application. |